Malaria and anemia

Current Opinion in Hematology

Volumn 10, Issue 2, 2003, Pages 108-114

  Ekvall, Håkan ^a,b  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b SUNDSVALL HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ANEMIA; BLOOD TRANSFUSION; BONE MARROW DEPRESSION; CELL DESTRUCTION; DISEASE ASSOCIATION; DISEASE SEVERITY; EPIDEMIOLOGICAL DATA; ERYTHROCYTE; HUMAN; MALARIA; MORBIDITY; MORTALITY; PATHOGENESIS; PHAGOCYTOSIS; PREGNANCY; PRIORITY JOURNAL; REVIEW;

ANEMIA; BONE MARROW; ERYTHROCYTES, ABNORMAL; FEMALE; HUMANS; INFANT; MALARIA; PREGNANCY;

EID: 0037370755     PISSN: 10656251     EISSN: None     Source Type: Journal    
DOI: 10.1097/00062752-200303000-00002     Document Type: Review

References (85)

1. Kurtzhals JA, Rodrigues O, Addae M, et al.: Reversible suppression of bone marrow response to erythropoietin in Plasmodium falciparum malaria. Br J Haematol 1997, 97:169-174.
2. Wickramasinghe SN, Abdalla SH: Blood and bone marrow changes in malaria. Baillieres Best Pract Res Clin Haematol 2000, 13:277-299.
3. Nussenblatt V, Mukasa G, Metzger A, et al.: Anemia and interleukin-10, tumor necrosis factor alpha, and erythropoietin levels among children with acute, uncomplicated Plasmodium falciparum malaria. Clin Diagn Lab Immunol 2001, 8:1164-1170.
4. Menendez C, Quinto LL, Kahigwa E, et al.: Effect of malaria on soluble transferrin receptor levels in Tanzanian infants. Am J Trop Med Hyg 2001, 65:138-142.
5. Verhoef H, West CE, Ndeto P, et al.: Serum transferrin receptor concentration indicates increased erythropoiesis in Kenyan children with asymptomatic malaria. Am J Clin Nutr 2001, 74:767-775.
6. Clark IA, Chaudhri G: Tumour necrosis factor may contribute to the anaemia of malaria by causing dyserythropoiesis and erythrophagocytosis. Br J Haematol 1988, 70:99-103.
7. Martiney JA, Sherry B, Metz CN, et al.: Macrophage migration inhibitory factor release by macrophages after ingestion of Plasmodium chabaudi-infected erythrocytes: possible role in the pathogenesis of malarial anemia. Infect Immun 2000, 68;2259-2267.
8. Kremsner PG, Greve B, Lell B, et al.: Malarial anaemia in African children associated with high oxygen-radical production. Lancet 2000, 355:40-41.
9. Kun JF, Mordmuller B, Perkins DJ, et al.: Nitric oxide synthase 2(Lambarene) (G-954C), increased nitric oxide production, and protection against malaria, J Infect Dis 2001, 184:330-336.
10. Schwarzer E, Turrini F, Ulliers D, et al.; Impairment of macrophage functions after ingestion of Plasmodium falciparum-infected erythrocytes or isolated malarial pigment. J Exp Med 1992, 176:1033-1041.
11. Ekvall H, Arese P, Turrini F, et al.: Acute haemolysis in childhood falciparum malaria. Trans R Soc Trop Med Hyg 2001, 95:611-617.
12. Dondorp AM, Angus BJ, Chotivanich K, et al.: Red blood cell deformability as a predictor of anemia in severe falciparum malaria. Am J Trop Med Hyg 1999, 60:733-737.
13. Egan AF, Fabucci ME, Saul A, et al.: Aotus New World monkeys: model for studying malaria-induced anemia. Blood 2002, 99:3863-3866.
14. Price RN, Simpson JA, Nosten F, et al.: Factors contributing to anemia after uncomplicated falciparum malaria. Am J Trop Med Hyg 2001, 65:614-622. • A prospective study of hematologic parameters in 4000 episodes of acute uncomplicated malaria in Thai adults.
15. Kurtzhals JA, Adabayeri V, Goka BQ, et al.: Low plasma concentrations of interleukin 10 in severe malarial anaemia compared with cerebral and uncomplicated malaria. Lancet 1998, 351:1768-1772.
16. Othoro C, Lal AA, Nahlen B, et al.: A low interleukin-10 tumor necrosis factor-alpha ratio is associated with malaria anemia in children residing in a holoendemic malaria region in western Kenya. J Infect Dis 1999, 179:279-282.
17. Griffiths MJ, Ndungu F, Baird KL, et al.: Oxidative stress and erythrocyte damage in Kenyan children with severe Plasmodium falciparum malaria. Br J Haematol 2001, 113:486-491.
18. Kiefer CR, Snyder LM: Oxidation and erythrocyte senescence. Curr Opin Hematol 2000, 7:113-116.
19. Waitumbi JN, Opollo MO, Muga RO, et al.: Red cell surface changes and erythrophagocytosis in children with severe plasmodium falciparum anemia. Blood 2000, 95:1481-1486.
20. Facer CA: Direct Coombs antiglobulin reactions in Gambian children with Plasmodium falciparum malaria. II. Specificity of erythrocyte-bound IgG. Clin Exp Immunol 1980, 39:279-288.
21. Facer CA, Bray RS, Brown J: Direct Coombs antiglobulin reactions in Gambian children with Plasmodium falciparum malaria. I. Incidence and class specificity. Clin Exp Immunol 1979, 35:119-127.
22. Goka BQ, Kwarko H, Kurtzhals JA, et al.: Complement binding to erythrocytes is associated with macrophage activation and reduced haemoglobin in Plasmodium falciparum malaria. Trans R Soc Trop Med Hyg 2001, 95:545-549.
23. WHO: Severe falciparum malaria. World Health Organization, Communicable Diseases Cluster. Trans R Soc Trop Med Hyg 2000, 94(suppl 1):S1-90.
24. Luty AJ, Perkins DJ, Lell B, et al.: Low interleukin-12 activity in severe Plasmodium falciparum malaria. Infect Immun 2000, 68:3909-3915.
25. Day NP, Hien TT, Schollaardt T, et al.: The prognostic and pathophysiologic role of pro- and antiinflammatory cytokines in severe malaria. J Infect Dis 1999, 180:1288-1297.
26. Dodoo D, Omer FM, Todd J, et al.: Absolute levels and ratios of proinflammatory and anti-inflammatory cytokine production in vitro predict clinical immunity to Plasmodium falciparum malaria. J Infect Dis 2002, 185:971-979.
27. Perkins DJ, Weinberg JB, Kremsner PG: Reduced interleukin-12 and transforming growth factor-beta1 in severe childhood malaria: relationship of cytokine balance with disease severity. J Infect Dis 2000, 182:988-992.
28. Greve B, Lehman LG, Lell B, et al.: High oxygen radical production is associated with fast parasite clearance in children with Plasmodium falciparum malaria. J Infect Dis 1999, 179:1584-1586.
29. Das BS, Nanda NK: Evidence for erythrocyte lipid peroxidation in acute falciparum malaria. Trans R Soc Trop Med Hyg 1999, 93:58-62.
30. Bratosin D, Mazurier J, Tissier JP, et al.: Cellular and molecular mechanisms of senescent erythrocyte phagocytosis by macrophages. A review. Biochimie 1998, 80:173-195.
31. Abdalla SH: Opsonizing and agglutinating antibodies against Plasmodium falciparum schizont-infected erythrocytes in Gambian sera. Trans R Soc Trop Med Hyg 1987, 81:214-218.
32. Giribaldi G, Ulliers D, Mannu F, et al.: Growth of Plasmodium falciparum induces stage-dependent haemichrome formation, oxidative aggregation of band 3, membrane deposition of complement and antibodies, and phagocytosis of parasitized erythrocytes. Br J Haematol 2001, 113:492-499.
33. Lutz HU, Fasler S, Stammler P, et al.: Naturally occurring anti-band 3 antibodies and comprement in phagocytosis of oxidatively-stressed and in clearance of senescent red cells. Blood Cells 1988, 14:175-203.
34. Camacho LH, Gordeuk VR, Wilairatana P, et al.: The course of anaemia after the treatment of acute, falciparum malaria. Ann Trop Med Parasitol 1998, 92:525-537.
35. Arese P, Schwarzer E: Malarial pigment (haemozoin): a very active "inert" substance. Ann Trop Med Parasitol 1997, 91:501-516.
36. Biemba G, Gordeuk VR, Thuma P, et al.: Markers of inflammation in children with severe malarial anaemia. Trop Med Int Health 2000, 5:256-262.
37. Burgmann H, Looareesuwan S, Kapiotis S, et al.: Serum levels of erythropoietin in acute Plasmodium falciparum malaria. Am J Trop Med Hyg 1996, 54:280-283.
38. el Hassan AM, Saeed AM, Fandrey J, et al.: Decreased erythropoietin response in Plasmodium falciparum malaria-associated anaemia. Eur J Haematol 1997, 59:299-304.
39. Schellenberg D, Menendez C, Kahigwa E, et al.: African chirdren with malaria in an area of intense Plasmodium falciparum transmission: features on admission to the hospital and risk factors for death. Am J Trop Med Hyg 1999, 61:431-438.
40. Trape JF: The public health impact of chloroquine resistance in Africa. Am J Trop Med Hyg 2001, 64:12-17.
41. Ekvall H, Premji Z, Bjorkman A: Chloroquine treatment for uncomplicated childhood malaria in an area with drug resistance: early treatment failure aggravates anaemia. Trans R Soc Trop Med Hyg 1998, 92:556-560.
42. Luxemburger C, Ricci F, Nosten F, et al.: The epidemiology of severe malaria in an area of low transmission in Thailand. Trans R Soc Trop Med Hyg 1997, 91;256-262.
43. Imbert P, Sarteret I, Rogier C, et al.: Severe malaria among children in a low seasonal transmission area, Dakar, Senegal: influence of age on clinical presentation. Trans R Soc Trop Med Hyg 1997, 91:22-24.
44. Baird JK: Age-dependent characteristics of protection v. susceptibility to Plasmodium falciparum. Ann Trop Med Parasitol 1998, 92:367-390.
45. Le Cessie S, Verhoeff FH, Mengistie G, et al.: Changes in haemoglobin leveis in infants in Malawi: effect of low birth weight and fetal anaemia. Arch Dis Child Fetal Neonatal Ed 2002, 86:F182-F187. • Describes the effect of maternal malaria and anemia on infant Hb patterns.
46. Kwiatkowski D: Genetic susceptibility to malaria getting complex. Curr Opin Genet Der 2000, 10:320-324.
47. Aidoo M, Terlouw DJ, Kolczak MS, et al.: Protective effects of the sickle cell gene against malaria morbidity and mortality. Lancet 2002, 359:1311-1312. • Describes the protective effect of the sickle cell trait against severe anemia in a highly malaria endemic area.
48. Modiano D, Luoni G, Sirima BS, et al.: Haemoglobin C protects against clinical Plasmodium falciparum malaria. Nature 2001, 414:305-308. • A case-control study of the malaria protection provided by hemoglobin C in 4000 West African subjects.
49. May J, Lell B, Luty AJ, et al.: Plasma interleukin-10:tumor necrosis factor (TNF)-alpha ratio is associated with TNF promoter variants and predicts malarial complications. J Infect Dis 2000, 182:1570-1573.
50. McGuire W, Knight JC, Hill AV, et al.: Severe malarial anemia and cerebral malaria are associated with different tumor necrosis factor promoter alleles. J Infect Dis 1999, 179:287-290.
51. Miller LH, Baruch DI, Marsh K, et al.: The pathogenic basis of malaria. Nature 2002, 415:673-679.
52. Akanmori BD, Kurtzhals JA, Goka BQ, et al.: Distinct patterns of cytokine regulation in discrete clinical forms of Plasmodium falciparum malaria. Eur Cytokine Netw 2000, 11:113-118.
53. Abdulla S, Schellenberg JA, Nathan R, et al.: Impact on malaria morbidity of a programme supplying insecticide treated nets in children aged under 2 years in Tanzania: community cross sectional study. BMJ 2001, 322:270-273.
54. Menendez C, Kahigwa E, Hirt R, et al.: Randomised placebo-controlled trial of iron supplementation and malaria chemoprophylaxis for prevention of severe anaemia and malaria in Tanzanian infants. Lancet 1997, 350:844-850.
55. Marchant T, Schellenberg JA, Edgar T, et al.: Socially marketed insecticide-treated nets improve malaria and anaemia in pregnancy in southern Tanzania. Trop Med Int Health 2002, 7:149-158.
56. Brabin BJ, Hakimi M, Pelletier D: An analysis of anemia and pregnancy-related maternal mortality. J Nutr 2001, 131:604S-614S; discussion 614S-615S. • A synthesis of available data on maternal mortality in relation to malaria and anemia.
57. Guyatt HL, Snow RW: The epidemiology and burden of Plasmodium falciparum-related anemia among pregnant women in sub-Saharan Africa. Am J Trop Med Hyg 2001, 64:36-44.
58. Shulman CE, Dorman EK, Cutts F, et al.: Intermittent sulphadoxine-pyrimethamine to prevent severe anaemia secondary to malaria in pregnancy: a randomised placebo-controlled trial. Lancet 1999, 353:632-636.
59. van den Broek NR, Letsky EA: Etiology of anemia in pregnancy in south Malawi. Am J Clin Nutr 2000, 72:247S-256S.
60. van den Broek N: Anaemia in pregnancy in sub-Saharan countries. Eur J Obstet Gynecol Reprod Biol 2001, 96:4-6.
61. Rush D: Nutrition and maternal mortality in the developing world. Am J Clin Nutr 2000, 72:212S-240S.
62. Garner P, Gulmezoglu AM: Prevention versus treatment for malaria in pregnant women. Cochrane Database Syst Rev 2000:CD000169.
63. van Eijk AM, Ayisi JG, ter Kuile FO, et al: Human immunodeficiency virus seropositivity and malaria as risk factors for third-trimester anemia in asymptomatic pregnant women in western Kenya. Am J Trop Med Hyg 2001, 65:623-630.
64. Rogerson SJ, van den Broek NR, Chaluluka E, et al: Malaria and anemia in antenatal women in Blantyre, Malawi: a twelve-month survey. Am J Trop Med Hyg 2000, 62:335-340.
65. Shulman CE, Marshall T, Dorman EK, et al.: Malaria in pregnancy: adverse effects on haemoglobin leveis and birthweight in primigravidae and multigravidae. Trop Med Int Health 2001, 6:770-778.
66. McElroy PD, ter Kuile FO, Lal AA, et al.: Effect of Plasmodium falciparum parasitemia density on hemoglobin concentrations among full-term, normal birth weight children in western Kenya, IV. The Asembo Bay Cohort Project. Aro J Trop Med Hyg 2000, 62:504-512.
67. Ekvall H, Premji Z, Bennett S, et al.: Hemoglobin concentration in children in a malaria holoendemic area is determined by cumulated Plasmodium falciparum parasite densities. Am J Trop Med Hyg 2001, 64:58-66.
68. Afolabi BM, Salako LA, Mafe AG, et al.: Malaria in the first 6 months of life in urban African infants with anemia. Am J Trop Med Hyg 2001, 65:822-827.
69. Steketee RW, Nahlen BL, Parise ME, et al.: The burden of malaria in pregnancy in malaria-endemic areas. Am J Trop Med Hyg 2001, 64:28-35.
70. Holding PA, Snow RW: Impact of Plasmodium falciparum malaria on performance and learning: review of the evidence. Am J Trop Med Hyg 2001, 64:68-75.
71. Stoltzfus RI, Kvalsvig JD, Chwaya HM, et al.: Effects of iron supplementation and anthelmintic treatment on motor and language development of preschool children in Zanzibar: double blind, placebo controlled study. BMJ 2001, 323:1389-1393.
72. Clark TD, Mmiro F, Ndugwa C, et al.: Risk factors and cumulative incidence of anaemia among human immunodeficiency virus-infected children in Uganda. Ann Trop Paediatr 2002, 22:11-17.
73. Moore RD: Human immunodeficiency vrus infection, anemia, and survival. Clin Infect Dis 1999, 29:44-49.
74. Brabin BJ, Premji Z, Verhoeff F: An analysis of anemia and child mortality. J Nutr 2001, 131:636S-645S; discussion 646S-648S. • A synthesis of available data on childhood mortality in relation to malaria and anemia.
75. WHO: Guidelines for the appropriate use of blood. Global Blood Safety Initiative/Global Programme on AIDS. Geneva: World Health Organization; 1989.
76. English M, Ahmed M, Ngando C, et al.: Blood transfusion for severe anaemia in children in a Kenyan hospital. Lancet 2002, 359:494-495.
77. Meremikwu M, Smith HJ: Blood transfusion for treating malarial anaemia. Cochrane Database Syst Rev 2000, 2.
78. Schellenberg D, Menendez C, Kahigwa E, et al.: Intermittent treatment for malaria and anaemia control at time of routine vaccinations in Tanzanian infants: a randomised, placebo-controlled trial. Lancet 2001, 357:1471-1477.
79. Tomashek KM, Woodruff BA, Gotway CA, et al.: Randomized intervention study comparing several regimens for the treatment of moderate anemia among refugee children in Kigoma Region, Tanzania. Am J Trop Med Hyg 2001, 64:164-171.
80. Verhoef H, West CE, Nzyuko SM, et al.: Intermittent administration of iron and sulfadoxine-pyrimethamine to control anaemia in Kenyan children: a randomised controlled trial. Lancet 2002, 360:908-914.
81. Nussenblatt V, Semba RD: Micronutrient malnutrition and the pathogenesis of malarial anemia. Acta Trop 2002, 82:321-337.
82. Ekvall H, Premji Z, Bjorkman A: Micronutrient and iron supplementation and effective antimalarial treatment synergistically improve childhood anaemia. Trop Med Int Health 2000, 5:696-705.
83. Muller O, Jahn A, von Braun J: Micronutrient supplementation for malaria control-hype or hope? Trop Med Int Health 2002, 7:1-3.
84. Shankar AH: Nutritional modulation of malaria morbidity and mortality. J Infect Dis 2000, 182(suppl 1):S37-53.
85. Oppenheimer SJ: Iron and its relation to immunity and infectious disease. J Nutr 2001, 131:616S-633S; discussion 633S-635S.